Cargando…
Gene Screening in High-Throughput Right-Censored Lung Cancer Data
BACKGROUND: Advances in sequencing technologies have allowed collection of massive genome-wide information that substantially advances lung cancer diagnosis and prognosis. Identifying influential markers for clinical endpoints of interest has been an indispensable and critical component of the stati...
Autores principales: | Ke, Chenlu, Bandyopadhyay, Dipankar, Acunzo, Mario, Winn, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100230/ https://www.ncbi.nlm.nih.gov/pubmed/37066112 http://dx.doi.org/10.3390/onco2040017 |
Ejemplares similares
-
Self‐reporting and screening: Data with right‐censored, left‐censored, and complete observations
por: Yefenof, Jonathan, et al.
Publicado: (2022) -
Gene Screening for Prognosis of Non-Muscle-Invasive Bladder Carcinoma under Competing Risks Endpoints
por: Ke, Chenlu, et al.
Publicado: (2023) -
Rotation survival forest for right censored data
por: Zhou, Lifeng, et al.
Publicado: (2015) -
Penalized regression for left‐truncated and right‐censored survival data
por: McGough, Sarah F., et al.
Publicado: (2021) -
Concordance indices with left-truncated and right-censored data
por: Hartman, Nicholas, et al.
Publicado: (2023)